Our Own Start-Up



SoySaponin, Inc., [‘SoySap’] established by Gary Brenner.  Our goal is to develop a game-changing market opportunity in important unmet health benefits to millions of individuals worldwide suffering from a range of gastrointestinal [GI] disorders, most commonly identified with IBD (Inflammatory Bowel Disease), Crohn’s Disease, Ulcerative Colitis, and certain symptoms related to IBS (Irritable bowel syndrome).

Soy Saponins are a natural component of the soybean, consumed by generations of humans and animals worldwide.  Soy Saponins have been researched widely, and have been shown to possess anti-inflammatory properties, important in modulating mammalian inflammation pathways which may lead to inhibition of some types of gastrointestinal diseases.  

While commercial focus has largely been elsewhere, many researchers and industry experts have concluded that the key benefits of soy may very well lie in the saponin compounds.

For further information contact:  garybrenner@pharmafood-bd.com